Publicatii:
1) N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis. (2020) Dobrica MO, Lazar C, Branza-Nichita N. Cells. 9(6):E1404. Published 2020 Jun 4. doi:10.3390/cells9061404, IF 5,6
2) A polycarboxylic chelating ligand for efficient resin purification of His-tagged proteins expressed in mammalian systems. (2020) Codruta C. Popescu, Marius C. Stoian, Lia-Maria Cucos, Anca G. Coman, Antonio Radoi, Anca Paun, Niculina D. Hadade, Arnaud Gautier, Costin-Ioan Popescu and Mihaela Matache. RSC Adv., 10, 23931, IF 4,03
3) Production of Chimeric Hepatitis B Virus Surface Antigens in Mammalian Cells. (2020) Mihaela-Olivia Dobrica, Catalin Lazar and Norica Branza-Nichita. Vaccine Delivery Technology: Methods and Protocols, Methods in Molecular Biology, Blaine Pfeifer and Andrew Hill (eds.), vol. 2183, https://doi.org/10.1007/978-1-0716-0795-4_7, © Springer Science+Business Media, LLC, part of Springer Nature. Book chapter.
4) Challenges and Prospects of Plant-Derived Oral Vaccines against Hepatitis B and C Viruses. (2021) Pantazica AM, Cucos LM, Stavaru C, Clarke JL, Branza-Nichita N. Plants (Basel), 10, 2037.https://doi.org/10.3390/plants10102037, IF 4,6
5) Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice. (2021) Dobrica MO, van Eerde A, Tucureanu C, Onu A, Paruch L, Caras I, Vlase E, Steen H, Haugslien S, Alonzi D, Zitzmann N, Bock R, Dubuisson J, Popescu CI, Stavaru C, Liu-Clarke J, Branza-Nichita N. Plant Biotechnology Journal, Oct;19(10):2027-2039, IF 9,8
6) Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS116-42 antigen (2022) Pantazica A-M, Dobrica MO, Lazar C, Scurtu C, Tucureanu C, Caras I, Ionescu I, Costcahe A, Onu A, Liu Clarke J, Stavaru C, Nichita N. Frontiers in Immunology, Jul 22;13:941243, IF 8.78
7) The "humanized" N-glycosylation pathway in CRISPR/Cas9-edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 Hepatitis B Virus antigen and the virus-neutralizing antibody response in vaccinated mice (2023) Ana-Maria Pantazica, André van Eerde, Mihaela-Olivia Dobrica, Iuliana Caras, Irina Ionescu, Adriana Costache, Catalin Tucureanu, Hege Steen, Catalin Lazar, Inger Heldal, Sissel Haugslien, Adrian Onu, Crina Stavaru, Norica Branza-Nichita, Jihong Liu Clarke. Plant Biotechnology Journal, doi: 10.1111/pbi.14028. Online ahead of print, IF 13.26
Conferinte:
1) A 49a Conferinta a Societatii Romane de Imunologie si a 4a Conferinta a Asociatiei Romane de Immuno-Dermatologie, 30.09-3.10.2020, Videoconferinta:
AM Pantazică*, OM Dobrică*, C Scurtu, N Nichita. "Production and characterization of novel HBV chimeric antigens". *Authors with equal contribution to this work.
LM Cucoș, TA Șulea, L.Spiridon, N Nichita, CI Popescu. “HCV Envelope Protein E2 Antigen Design and Characterization for Vaccine Development”
3) Simpozionul Anual al INCDMM “Cantacuzino”. 25.11.2021
Nichita N, “Production of novel vaccine antigens derived from the Human Hepatitis B Virus” (Key lecture)
4) Simpozionul Anual al "Protein Society" (USA), July 7-14, 2021
Pantazică A-M, Dobrică MO, Scurtu C, Nichita N, “Production and Characterization of Novel HBV Chimeric Antigens”, (poster presentation)
Cucos L-M, Sulea T, Caras I, Spiridon L, Stavaru C, Nichita N, Popescu CI, “Hepatitis C Virus envelope protein E2 based antigen design and characterization for vaccine development”, (poster presentation)
5) Conferinta Internationala Anuala a Societatii Romane de Biochimie si Biologie Moleculara, Iași, 26-27 Septembrie, 2019
MO Dobrica, L. Paruch, D. Alonzi, N. Zitzmann, CI Popescu, J. Dubuison, J. Liu-Clarke, N. Nichita, “Generation and characterization of HCV-E2 antigen in Nicotiana Benthamiana leaves for vaccine development”, (poster presentation)
6) 2022 International HBV Meeting, 18 – 22 September 2022, Paris, France.
Ana-Maria Pantazica, Mihaela-Olivia Dobrica, Catalin Lazar, Cristina Scurtu, Catalin Tucureanu, Iuliana Caras, Irina Ionescu, Adriana Costache, Adrian Onu, Jihong Liu- Clarke, Crina Stavaru, Norica Nichita. “Novel Hepatitis B S/preS1 chimeric antigen induces efficient cellular and humoral immune response and production of virus-neutralizing antibodies”, (prezentare poster)
7) FEBS-IUBMB-ENABLE 2022, 16 - 18 November 2022, Seville, Spain
Ana-Maria Pantazica, Mihaela-Olivia Dobrica, Catalin Lazar, Cristina Scurtu, Catalin Tucureanu, Iuliana Caras, Irina Ionescu, Adriana Costache, Adrian Onu, Jihong Liu- Clarke, Crina Stavaru, Norica Branza-Nichita. "Novel chimeric Hepatitis B S/preS1 antigen induces efficient cellular and humoral immune response and production of virus-neutralizing antibodies" (scurta prezentare orala)
Cucos Lia-Maria, Teodor Asvadur Sulea, Laurentiu Spiridon, Norica Nichita, Costin-Ioan Popescu. "Hepatitis C Virus Envelope Protein E2 Antigen Design and Characterization for Vaccine Development", (prezentare poster)
8) Conferinta Anuala a Studentilor Doctoranzi ai Institutului de Biochimie, 12 Decembrie, 2022
Ana-Maria Pantazica, Mihaela-Olivia Dobrica, Catalin Lazar, Cristina Scurtu, Catalin Tucureanu, Iuliana Caras, Irina Ionescu, Adriana Costache, Adrian Onu, Jihong Liu- Clarke, Crina Stavaru, Norica Nichita “Production and characterization of chimeric subviral particles for the development of a novel HBV vaccine”, (prezentare orala)
Cucos Lia-Maria, Teodor Asvadur Sulea, Laurentiu Spiridon, Norica Nichita, Costin-Ioan Popescu.“Production and characterization of HCV antigens based on the envelope protein E2, for vaccine development”, (prezentare orala)
EEA Grants (2014-2021)
Dezvoltare de vaccinuri de ultima generație împotriva Virusurilor Hepatice B și C în plante și alge, utilizând metode biotehnologice avansate
Acronimul proiectului: SmartVac
Durata: 48 de luni
(03/06/2019-02/06/2023)
Finanțare: 7.127.550,00 lei
SmartVac © 2020 • Created with WebWave